Innovative Eyewear Inc. (LUCY)vsMerck & Company Inc (MRK)
LUCY
Innovative Eyewear Inc.
$1.05
+0.96%
HEALTHCARE · Cap: $6.49M
MRK
Merck & Company Inc
$109.18
+2.74%
HEALTHCARE · Cap: $274.03B
Smart Verdict
WallStSmart Research — data-driven comparison
Merck & Company Inc generates 2442362% more annual revenue ($65.01B vs $2.66M). MRK leads profitability with a 28.1% profit margin vs -285.2%. MRK earns a higher WallStSmart Score of 59/100 (C).
LUCY
Hold36
out of 100
Grade: F
MRK
Buy59
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+39.2%
Fair Value
$1.81
Current Price
$1.05
$0.76 discount
Margin of Safety
-13.2%
Fair Value
$96.48
Current Price
$109.18
$12.70 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Revenue surging 39.0% year-over-year
Mega-cap, among the largest globally
Every $100 of equity generates 37 in profit
Strong operational efficiency at 32.8%
Keeps 28 of every $100 in revenue as profit
Attractively priced relative to earnings
Generating 1.8B in free cash flow
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -83.6% — below average capital efficiency
Negative free cash flow — burning cash
Weak financial health signals
Expensive relative to growth rate
Earnings declined 19.3%
Comparative Analysis Report
WallStSmart ResearchBull Case : LUCY
The strongest argument for LUCY centers on Price/Book, Revenue Growth. Revenue growth of 39.0% demonstrates continued momentum.
Bull Case : MRK
The strongest argument for MRK centers on Market Cap, Return on Equity, Operating Margin. Profitability is solid with margins at 28.1% and operating margin at 32.8%.
Bear Case : LUCY
The primary concerns for LUCY are EPS Growth, Market Cap, Return on Equity.
Bear Case : MRK
The primary concerns for MRK are Piotroski F-Score, PEG Ratio, EPS Growth.
Key Dynamics to Monitor
LUCY profiles as a hypergrowth stock while MRK is a value play — different risk/reward profiles.
LUCY carries more volatility with a beta of 3.06 — expect wider price swings.
LUCY is growing revenue faster at 39.0% — sustainability is the question.
MRK generates stronger free cash flow (1.8B), providing more financial flexibility.
Bottom Line
MRK scores higher overall (59/100 vs 36/100), backed by strong 28.1% margins. LUCY offers better value entry with a 39.2% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Innovative Eyewear Inc.
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Innovative Eyewear Inc. (LUCY) is a pioneering player in the smart eyewear sector, skillfully merging advanced technology with modern aesthetics to meet the needs of tech-savvy consumers. Its flagship line, Lucyd, stands out by integrating audio features and connectivity into stylish eyewear, thus providing both versatility and fashion. With a strong focus on innovation and enhancing user experiences, the company is well-positioned to harness the growing demand for multifunctional wearables, indicating significant growth potential in the rapidly evolving eyewear market. As trends shift towards smart solutions, LUCY's strategic approach positions it favorably for long-term success.
Merck & Company Inc
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668.
Visit Website →Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?